Dopamine and Serotonin Receptors: Amino Acid Sequences, and Clinical Role in Neuroleptic Parkinsonism
Open Access
- 1 January 1996
- journal article
- review article
- Published by Elsevier in The Japanese Journal of Pharmacology
- Vol. 71 (3) , 187-204
- https://doi.org/10.1254/jjp.71.187
Abstract
This review summarizes the amino acid sequences of the human dopamine and serotonin receptors and their human variants. The review also examines the receptor basis of the atypical antipsychotic drugs that elicit less parkinsonism than the typical antipsychotics. Because the dissociation constant of a drug varies with the radioligand, the dissociation constants of many neuroleptics are here summarized for the dopamine D2-, D4- and serotonin S2A-receptors using different radioligands. Radioligands of low solubility in the membrane (having low tissue/buffer partition) result in lower values for the neuroleptic dissociation constants, compared to radioligands of high membrane solubility. Such studies yield the intrinsic K value for a neuroleptic in the absence of a competing ligand. Clozapine, for example, has an intrinsic K value of 1.6 nM at the D4-receptor, in agreement with the value of 1.6 nM when directly measured with [3H]clozapine at D4. However, because clozapine competes with endogenous dopamine, the in vivo clozapine concentration to occupy 75% of the dopamine D4-receptors is derived to be approximately 13 nM. This agrees with the value of 12 to 20 nM in the plasma water (or spinal fluid) observed in treated patients. Moreover, in L-DOPA psychosis (in Parkinson's disease), the clozapine concentration for 75% blockade of D4 is predicted to be approximately 3 nM. This agrees with the value of approximately 1.2 nM observed by Meltzer et al. in plasma water (Neuropsychopharmacology, 12, 39-45 (1995)). This analysis supports the concept and practical value of the intrinsic K values. Some atypical neuroleptics (remoxipride, clozapine, perlapine, seroquel and melperone) have high intrinsic K values (ranging from 30 to 88 nM) at the D2-receptor, making them displaceable by high levels of endogenous dopamine in the caudate/putamen. In contrast, however, typical neuroleptics (i.e., those that typically cause parkinsonism) have intrinsic K values of 0.3 to 6 nM, making them less displaceable by endogenous dopamine. A relationship exists between the neuroleptic doses for rat catalepsy and the D2/D4 ratio of the intrinsic K values. Thus, the atypical neuroleptics appear to fall into two groups, those that bind loosely to D2 and those that are selective at D4.Keywords
This publication has 84 references indexed in Scilit:
- Identification of Genetic Variation in the Human Serotonin 1Dβ Receptor GeneBiochemical and Biophysical Research Communications, 1994
- A Structural Polymorphism of Human Dopamine D2 Receptor D2(Ser311 → Cys)Biochemical and Biophysical Research Communications, 1993
- Antagonism by 8-OH-DPAT, but not ritanserin, of catalepsy induced by SCH 23390 in the ratJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1992
- Cloning of the human serotonin 5-HT2 and 5-HT1C receptor subtypesBiochemical and Biophysical Research Communications, 1991
- Human dopamine D5 receptor pseudogenesGene, 1991
- Alternative transcripts of the rat and human dopamine D3 receptorBiochemical and Biophysical Research Communications, 1991
- Antipsychotic-like profile of combined treatment with raclopride and 8-OH-DPAT in the rat: enhancement of antipsychotic-like effects without catalepsyJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1991
- The effect of serotonergic agents on haloperidol-induced catalepsyLife Sciences, 1990
- Exogenous 1-dopa alters spiroperidol binding, invivo, in the mouse striatumLife Sciences, 1986
- Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reactionBiochemical Pharmacology, 1973